LDH-IN-2, a salicylic acid derivative, is an inhibitor of glycolate oxidase (GO). LDH-IN-2 decreases oxalate output in hyperoxaluric hepatocytes. LDH-IN-2 can be used for research of primary hyperoxaluria type 1 (PH1)[1].
Molecular Weight:
204.18
CAS Number:
[893739-96-3]
Formula:
C11H8O4
Target:
Others
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted